Mechanisms of sulfonylurea receptor mediated cardiomyopathy
Mechanisms of sulfonylurea receptor mediated cardiomyopathy
批准号:
8839048
负责人:
JONATHAN C MAKIELSKI
金额:
$63.75万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-12-01 至 2018-11-30
关键词:
ATP-Binding Cassette TransportersAblationAdultAlternative SplicingBindingBlood VesselsCRSP3 geneCantu syndromeCardiacCardiac MyocytesCardiomegalyCardiomyopathiesCell RespirationCellsCharacteristicsClinicalComplexConsumptionCoronary arteryCouplesDataDiabetes MellitusDilated CardiomyopathyDiseaseDrug DesignDrug usageEnergy SupplyEquilibriumExonsGenesGeneticGenetically Engineered MouseGlucoseGlyburideGrowthHeartHeart failureHumanHypertensionIntegral Membrane ProteinIschemiaIschemic PreconditioningLengthLifeLinkMediatingMembrane PotentialsMetabolicMetabolismMitochondriaModelingMusMutationMyocardial IschemiaMyocardiumNeonatalNewborn InfantNucleotidesPathway interactionsPerinatal mortality demographicsPharmaceutical PreparationsPotassiumPotassium ChannelProductionProteinsRegulationReperfusion InjuryReportingRoleSarcomeresSignal TransductionSourceSpasmStressSulfonylurea CompoundsTestingTissuesTransgenic OrganismsVentricularcardiovascular disorder riskcardiovascular risk factordensitydiabeticfatty acid oxidationglucose metabolismimprovednovelnucleotide binding foldnutritionoverexpressionpreconditioningpublic health relevanceresearch studyresponsesudden cardiac deathsulfonylurea receptor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): ATP-sensitive potassium (KATP) channels response to the intracellular energy state of the cell through directly nucleotide binding. KATP channels sense intracellular ADP content and, in response, regulate membrane potential. The major KATP regulatory component found in the ventricular cardiomyocyte is the sulfonylurea receptor (SUR)-2, encoded by the Abcc9 gene. Like other ABC transporter proteins, SUR2 is a multi- transmembrane protein with two nucleotide-binding folds. Glyburide, a sulfonylurea antagonist, is used commonly to treat diabetes, although this class of medications has been reported to increase cardiovascular risk in diabetics. The clinical use of drugs that act through the SURs, as well as the possibility to develop additional agents that utilize these pathways, argues for improved understanding of SURs and their role especially in high energy demand tissue like the heart. Mutations in the Abcc9/SUR2 gene cause dilated cardiomyopathy and more recently have been linked to Cantu syndrome, a rare multisystem disorder that includes cardiomegaly (Harakalova et al., 2012; van Bon et al., 2012). The Abcc9 gene undergoes alternative splicing to produce SUR2, a characteristic ATP binding cassette protein, and also a smaller 55 KDa protein, which we termed SUR2- 55. Like SUR2, SUR2-55 can couple with the partner potassium channel but SUR2-55 is enriched in mitochondria. Deletion of the Abcc9 gene in a manner that leaves SUR2-55 intact, leads to coronary artery vascular spasm, hypertension, sudden cardiac death. In contrast, deletion of Abcc9 in a manner that ablate both SUR2 and SUR2-55 leads to neonatal cardiomyopathy in the first 10 days of life. The newborn heart is known to transition from glucose to oxidative metabolism during this window, and this transition is impaired in Abcc9 deleted mice. In separate experiments, we found that transgenic overexpression of SUR-55 in the heart protects the heart from ischemic reperfusion injury. We hypothesize that Abcc9-encoded proteins, through KATP channels, contribute to the metabolic balance especially under stress conditions such as the newborn heart and in ischemic myocardium. Ablation of Abbc9 in the newborn and adult myocardium will be used to define SUR2 complexes and their role in the heart.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms for arrhythmia: Nitrosylation and mutations in the Na current complex
-
批准号:8914118
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2015
-
负责人:JONATHAN C MAKIELSKI
-
依托单位:
Mechanisms for arrhythmia: Nitrosylation and mutations in the Na current complex
-
批准号:9119036
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2015
-
负责人:JONATHAN C MAKIELSKI
-
依托单位:
Mechanisms for arrhythmia: Nitrosylation and mutations in the Na current complex
-
批准号:9330245
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2015
-
负责人:JONATHAN C MAKIELSKI
-
依托单位:
Mechanisms of sulfonylurea receptor mediated cardiomyopathy
-
批准号:8976166
-
项目类别:
-
资助金额:$61.62万
-
财政年份:2014
-
负责人:JONATHAN C MAKIELSKI
-
依托单位:
Inward Rectifier K Channel and Ca-Dependent Arrhythmia
-
批准号:8134097
-
项目类别:
-
资助金额:$65.78万
-
财政年份:2010
-
负责人:JONATHAN C MAKIELSKI
-
依托单位:
Cellular & Clinical Phenotypes of Novel SCN5a Mutations
-
批准号:6944832
-
项目类别:
-
资助金额:$36.38万
-
财政年份:2003
-
负责人:JONATHAN C MAKIELSKI
-
依托单位:
Cellular & Clinical Phenotypes of Novel SCN5a Mutations
-
批准号:7112397
-
项目类别:
-
资助金额:$35.52万
-
财政年份:2003
-
负责人:JONATHAN C MAKIELSKI
-
依托单位:
Cellular & Clinical Phenotypes of Novel SCN5a Mutations
-
批准号:6801168
-
项目类别:
-
资助金额:$36.38万
-
财政年份:2003
-
负责人:JONATHAN C MAKIELSKI
-
依托单位:
Cellular and clinical phenotypes of novel SCN5a mutations
-
批准号:7642478
-
项目类别:
-
资助金额:$40.57万
-
财政年份:2003
-
负责人:JONATHAN C MAKIELSKI
-
依托单位:
Cellular and clinical phenotypes of novel SCN5a mutations
-
批准号:8081018
-
项目类别:
-
资助金额:$40.54万
-
财政年份:2003
-
负责人:JONATHAN C MAKIELSKI
-
依托单位:
Cellular & Clinical Phenotypes of Novel SCN5a Mutations
-
批准号:6612188
-
项目类别:
-
资助金额:$36.38万
-
财政年份:2003
-
负责人:JONATHAN C MAKIELSKI
-
依托单位:
Cellular and clinical phenotypes of novel SCN5a mutations
-
批准号:7527779
-
项目类别:
-
资助金额:$39.39万
-
财政年份:2003
-
负责人:JONATHAN C MAKIELSKI
-
依托单位:
Cellular and clinical phenotypes of novel SCN5a mutations
-
批准号:7884375
-
项目类别:
-
资助金额:$40.95万
-
财政年份:2003
-
负责人:JONATHAN C MAKIELSKI
-
依托单位:
The cardiac Na current macromolecular complex and role in arrhythmia mechanism
-
批准号:8903545
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2002
-
负责人:JONATHAN C MAKIELSKI
-
依托单位:
Training Program in Translational Cardiovascular Science
-
批准号:7911765
-
项目类别:
-
资助金额:$34.1万
-
财政年份:2001
-
负责人:JONATHAN C MAKIELSKI
-
依托单位:
Training Program in Translational Cardiovascular Science
-
批准号:7679410
-
项目类别:
-
资助金额:$40.82万
-
财政年份:2001
-
负责人:JONATHAN C MAKIELSKI
-
依托单位:
Training Program in Translational Cardiovascular Science
-
批准号:8019232
-
项目类别:
-
资助金额:$42.56万
-
财政年份:2001
-
负责人:JONATHAN C MAKIELSKI
-
依托单位:
Training Program in Translational Cardiovascular Science
-
批准号:8721473
-
项目类别:
-
资助金额:$45.81万
-
财政年份:2001
-
负责人:JONATHAN C MAKIELSKI
-
依托单位:
Training Program in Translational Cardiovascular Science
-
批准号:9389695
-
项目类别:
-
资助金额:$0.57万
-
财政年份:2001
-
负责人:JONATHAN C MAKIELSKI
-
依托单位:
Training Program in Translational Cardiovascular Science
-
批准号:6771784
-
项目类别:
-
资助金额:$37.55万
-
财政年份:2001
-
负责人:JONATHAN C MAKIELSKI
-
依托单位:
海外基金